LENZ Therapeutics, Inc. Stock
Stocks
LENZ
US52635N1037
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Nasdaq
16:00:00 2026-09-10 EDT
|
5-day change | 1st Jan Change | ||
| 4.720 USD | -3.87% |
|
-19.04% | -70.50% |
| 08-11 | LENZ Therapeutics, Inc., Q2 2026 Earnings Call, Aug 11, 2026 | |
| 08-11 | LENZ Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| Market Cap | 148M 128M 120M 110M 205M 14.18B 207M 1.43B 552M 7.19B 557M 545M 22.84B | P/E 2026 * |
-1.11x | P/E 2027 * | -1.53x |
|---|---|---|---|---|---|
| Enterprise Value | 148M 128M 120M 110M 205M 14.18B 207M 1.43B 552M 7.19B 557M 545M 22.84B | EV / Sales 2026 * |
8.73x | EV / Sales 2027 * | 3.45x |
| Free-Float |
97.35% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| LENZ | Delayed | |
CBOE
| LENZ | Real-time |
Last Transcript : LENZ Therapeutics, Inc.
| 1 day | -3.87% | ||
| 1 week | -19.04% | ||
| Current month | -9.40% | ||
| 1 month | -11.94% | ||
| 3 months | -28.27% | ||
| 6 months | -60.47% | ||
| Current year | -70.50% |
| 1 week | 4.68 |  | 5.95 |
| 1 month | 4.54 | | 6.74 |
| Current year | 4.54 | | 21.8 |
| 1 year | 4.54 | | 50.4 |
| 3 years | 4.54 | | 50.4 |
| 5 years | 4.54 | | 50.4 |
| 10 years | 4.54 | | 50.4 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 3/27/26 | Buy | Chief Executive Officer | 28,089 | 0.0898% | ||
| 3/27/26 | Buy | Chief Financial Officer | 7,500 | 0.0240% | ||
| 3/27/26 | Buy | Chairman | 5,592 | 0.0179% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.87% | -19.04% | -88.68% | - | 148M | |
| -0.25% | -1.36% | +44.08% | +102.76% | 68.24B | |
| +0.86% | -3.40% | +31.83% | +75.55% | 62.23B | |
| -1.18% | +0.47% | -12.78% | +384.69% | 27.8B | |
| -1.05% | -4.43% | +30.56% | +10.07% | 24.86B | |
| -1.76% | -6.30% | -4.55% | -19.75% | 24.22B | |
| +0.22% | -3.65% | +14.52% | -19.52% | 19.36B | |
| -1.86% | -2.22% | +202.03% | +353.89% | 17.28B | |
| -1.94% | -4.94% | -5.29% | +495.65% | 14.46B | |
| -1.54% | -2.88% | +52.33% | +159.75% | 14.23B | |
| Average | -1.25% | -4.88% | +26.40% | +171.45% | 27.28B | |
| Weighted average by Cap. | -0.53% | -3.11% | +35.59% | +137.00% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 16.99M 14.61M 13.79M 12.56M 23.48M 1.62B 23.69M 164M 63.19M 824M 63.8M 62.4M 2.62B | 42.99M 36.97M 34.88M 31.78M 59.41M 4.11B 59.95M 415M 160M 2.08B 161M 158M 6.62B |
| Net income | -137M -118M -111M -101M -189M -13.07B -191M -1.32B -508M -6.63B -513M -502M -21.05B | -104M -89.2M -84.16M -76.67M -143M -9.92B -145M -1B -386M -5.03B -389M -381M -15.98B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-10 | US$4.720 | -3.87% | 569,054 |
| 26-09-09 | US$4.910 | -7.88% | 705,801 |
| 26-09-08 | US$5.330 | -10.57% | 642,871 |
| 26-09-04 | US$5.960 | +2.23% | 488,956 |
| 26-09-03 | US$5.830 | +0.52% | 835,136 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- LENZ Stock
Select your edition
All financial news and data tailored to specific country editions
